Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Biology & Therapy|December 23, 2003
Caspase 10 levels are increased following DNA damage in a p53-dependent mannerBart Rikhof, Paul G Corn, Wafik S El-Deiry
Cancer Treatment and Research Communications|April 18, 2025
Pembrolizumab after platinum-based chemotherapy for metastatic urothelial cancer: comparison between patients from a Dutch nationwide cohort and KEYNOTE-045Anke Richters, Britt Suelmann, Mira Franken, et al.
The Journal of Pathology|January 17, 2009
The insulin-like growth factor system and sarcomasBart Rikhof, Steven de Jong, Albert J H Suurmeijer, et al.
Endocrine-Related Cancer|November 30, 2007
Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new casesJan Willem B de Groot, Bart Rikhof, Jaap van Doorn, et al.
European Journal of Cancer (Oxford, England : 1990)|December 20, 2020
Serial [18F]-FDHT-PET to predict bicalutamide efficacy in patients with androgen receptor positive metastatic breast cancerJorianne Boers, Clasina M Venema, Erik F J de Vries, et al.
The American Journal of Pathology|June 5, 2012
'Big'-insulin-like growth factor-II signaling is an autocrine survival pathway in gastrointestinal stromal tumorsBart Rikhof, Winette T A van der Graaf, Albert J H Suurmeijer, et al.
European Urology Open Science|November 1, 2024
PrimerX: A Bayesian Multistage Cohort Embedded Randomised Trial to Evaluate the Role of Deferred Local Therapy of the Primary Tumour in Combination with Immune Checkpoint Inhibitor-based First-line Therapy in Metastatic Renal Cell Carcinoma PatientsOrlane Figaroa, Patricia Zondervan, Rob Kessels, et al.
Anticancer Research|October 13, 2012
The impact of age on outcome of embryonal and alveolar rhabdomyosarcoma patients. A multicenter studyJorieke C Van Gaal, Winette T A Van Der Graaf, Bart Rikhof, et al.
European Journal of Cancer (Oxford, England : 1990)|June 23, 2026
Response and survival in unresectable in-transit metastatic melanoma according to treatment strategyCato Boreel, Jessie de Ruijter, Olivier van Not, et al.
Pageof 1